Home  >  TopNews
  Xperia Healthcare files trade mark opposition against Matrix Healthcare for passing off case of hypertension drug,   November 15, 2018
  Bombay HC imposes Rs.1.5 cr fine on Galpha Labs for violating Glenmark's trademark,   September 03, 2018
  FICCI seeks amendment in Form 27 & patent law to facilitate commercialisation of patented product & ease of doing business,   April 16, 2018
  Pharma associations from India, America and Japan seek amendment to Sec 146 of Patents Act for working of patents,   April 11, 2018
  Indian Pharmaceutical Alliance urges govt to effectively use patent law to safeguard public health,   April 09, 2018
  Patent experts call on govt to amend Form 27 for 'working of patents' more precise and transparent,   April 04, 2018
  IPR protection becomes big challenge for pharma industry in internet era: Expert,   April 03, 2018
  Origiin IP Solutions sees opposition and revocation of patent important for pharma industry,   March 17, 2018
  Civil society groups appeal to PM to issue CL for J&J's patented DR-TB drugs bedaquiline and delamanid,   March 14, 2018
  IPA criticises GIPC's continued tirade against India for keeping India on 'Priority Watch List',   February 17, 2018
  Indian Pharmaceutical Alliance appeals to USTR to remove India from Priority Watch List,   February 09, 2018
  Origiin IP calls to file ANDA application with the US FDA to thwart patent infringement risk for generic drug approval,   January 17, 2018
  K&S Partners sees grant of patent has no direct correlation to access life-saving medicines,   November 10, 2017
  ICMR releases Handbook on IPR & Technology Transfer to step up awareness among scientists,   October 30, 2017
  Health ministry can invoke provision of Patent Act to reduce cost of procurement of Prevnar 13 under UIP: says Dr Nair,   October 30, 2017
  MSF appeals to Korea, Japan to withdraw proposals hindering access to generic drugs & vaccines from RCEP negotiations,   October 25, 2017
  Indian Patent Act achieved balance between drug innovators & public health: Dr BR Jagashetty,   October 13, 2017
  Experts see value of pharma patents in India can encourage research for novel drugs,   October 06, 2017
  MSF fears some provisions in India-EFTA trade talks will erode India‚Äôs ability to supply generic drugs across developing world,   May 31, 2017
  Civil society organizations ask University of California to withdraw efforts to obtain patent on prostate cancer drug enzalutamide in India,   May 29, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |